| Revenue | 120,205.59a | 106,252.34a |
| Cost of sales (-) | -82,047.4a | -77,224.73a |
| Gross profit | 38,158.19a | 29,027.61a |
| General administrative expenses (-) | -5,275.65a | -4,891.2a |
| Marketing expenses (-) | -2,629.61a | -2,088.46a |
| Research and development expenses (-) | -3,318.26a | -3,819.91a |
| Other operating income | 17,478.74a | 48,391.37a |
| Other operating expenses (-) | -17,097.77a | -30,562.63a |
| Operating profit | 27,315.64a | 36,056.79a |
| Income from investing activities | 85.1a | 49.54a |
| Shares of profit of equity accounted investees | -57.99a | -2.13a |
| Operating profit before financial expense | 27,342.74a | 36,104.2a |
| Financial income | 1,768.19a | 1,706.12a |
| Financial expense (-) | -6,975.66a | -12,753.7a |
| Monetary gain/(loss) | -13,869.43a | -14,647.44a |
| Profit before tax from continuing operations | 8,265.85a | 10,409.18a |
| Tax income from continuing operations | 6,956.87a | 237.7a |
| Current corporate tax expense (-) | -54.07a | -1,630.38a |
| Deferred tax income | 7,010.94a | 1,868.07a |
| Profit for the period from continuing operations | 15,222.72a | 10,646.87a |
| Profit for the period attributable to | 15,222.72a | 10,646.87a |
| Non-controlling interest | -76.02a | 120.98a |
| Owners of the company | 15,298.74a | 10,525.9a |